These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 18752153

  • 61. Low serum testosterone levels are associated with positive surgical margins in radical retropubic prostatectomy: hypogonadism represents bad prognosis in prostate cancer.
    Teloken C, Da Ros CT, Caraver F, Weber FA, Cavalheiro AP, Graziottin TM.
    J Urol; 2005 Dec; 174(6):2178-80. PubMed ID: 16280759
    [Abstract] [Full Text] [Related]

  • 62. Detectable prostate specific antigen between 60 and 120 days following radical prostatectomy for prostate cancer: natural history and prognostic significance.
    Sengupta S, Christensen CM, Zincke H, Slezak JM, Leibovich BC, Bergstralh EJ, Myers RP, Blute ML.
    J Urol; 2006 Aug; 176(2):559-63. PubMed ID: 16813889
    [Abstract] [Full Text] [Related]

  • 63. Photodynamic diagnosis using 5-aminolevulinic acid for the detection of positive surgical margins during radical prostatectomy in patients with carcinoma of the prostate: a multicentre, prospective, phase 2 trial of a diagnostic procedure.
    Adam C, Salomon G, Walther S, Zaak D, Khoder W, Becker A, Reich O, Blana A, Ganzer R, Denzinger S, Popken G, Sroka R, Knüchel-Clarke R, Köllermann J, Sauter G, Hartmann A, Bertz S, Graefen M, Huland H, Wieland W, Stief CG.
    Eur Urol; 2009 Jun; 55(6):1281-8. PubMed ID: 19328622
    [Abstract] [Full Text] [Related]

  • 64. Prognostic value of prostate secretory protein of 94 amino acids and its binding protein after radical prostatectomy.
    Reeves JR, Dulude H, Panchal C, Daigneault L, Ramnani DM.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 1):6018-22. PubMed ID: 17062675
    [Abstract] [Full Text] [Related]

  • 65. Preoperative and intraoperative risk factors for side-specific positive surgical margins in laparoscopic radical prostatectomy for prostate cancer.
    Secin FP, Serio A, Bianco FJ, Karanikolas NT, Kuroiwa K, Vickers A, Touijer K, Guillonneau B.
    Eur Urol; 2007 Mar 15; 51(3):764-71. PubMed ID: 17098356
    [Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy.
    Bastian PJ, Palapattu GS, Yegnasubramanian S, Lin X, Rogers CG, Mangold LA, Trock B, Eisenberger M, Partin AW, Nelson WG.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 1):5361-7. PubMed ID: 17875764
    [Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71. The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer.
    Kositsawat J, Flanigan RC, Meydani M, Choi YK, Freeman VL.
    J Urol; 2007 Dec 15; 178(6):2391-6; discussion 2396. PubMed ID: 17936811
    [Abstract] [Full Text] [Related]

  • 72. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
    Freedland SJ, Sun L, Kane CJ, Presti JC, Terris MK, Amling CL, Moul JW, Aronson WJ.
    BJU Int; 2008 Sep 15; 102(8):969-74. PubMed ID: 18691175
    [Abstract] [Full Text] [Related]

  • 73. The influence of extent of surgical margin positivity on prostate specific antigen recurrence.
    Emerson RE, Koch MO, Jones TD, Daggy JK, Juliar BE, Cheng L.
    J Clin Pathol; 2005 Oct 15; 58(10):1028-32. PubMed ID: 16189146
    [Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77. Maximal tumor diameter and the risk of PSA failure in men with specimen-confined prostate cancer.
    Dvorak T, Chen MH, Renshaw AA, Loffredo M, Richie JP, D'Amico AV.
    Urology; 2005 Nov 15; 66(5):1024-8. PubMed ID: 16286117
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.